Zurich Cantonal Bank
ACET icon

Zurich Cantonal Bank’s Adicet Bio ACET Stock Holding History

Zurich Cantonal Bank’s Portfolio ACET Stock Details ACET Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Hold
0
– -$5 – 2640
2024
Q1 		– Hold
0
– – – 2702
2023
Q4 		– Hold
0
– – – 2722
2023
Q3 		– Hold
0
– – – 2784
2023
Q2 		– Sell
-363
Closed -$32K – 2794
2023
Q1 		$33.5K Sell
363
-85
-19% -$10.7K ﹤0.01% 2684
2022
Q4 		$64K Buy
448
+343
+327% +$85.6K ﹤0.01% 2516
2022
Q3 		$24K Hold
105
– – ﹤0.01% 2764
2022
Q2 		$24K Hold
105
– – ﹤0.01% 2766
2022
Q1 		$33K Buy
105
+43
+69% +$9.89K ﹤0.01% 2597
2021
Q4 		$17K Buy
+62
New +$10.6K ﹤0.01% 2869

Other funds holding ACET

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

Zurich Cantonal Bank's ACET Position: Q2 2024 in Review

Zurich Cantonal Bank held its Adicet Bio (ACET) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2640.

Zurich Cantonal Bank first reported a position in ACET in Q4 2021 and has held it in 6 quarters since. The position peaked at $64K in Q4 2022. 86 funds tracked by Wall St. Rank hold ACET as of Q2 2024.

  • Zurich Cantonal Bank held 0 shares of Adicet Bio worth $0 as of Q2 2024.
  • Zurich Cantonal Bank left its Adicet Bio share count unchanged in Q2 2024.
  • Adicet Bio made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2024, its #2640 holding.
  • Zurich Cantonal Bank first reported a position in Adicet Bio in Q4 2021 and has held it in 6 quarters since.
  • Zurich Cantonal Bank's Adicet Bio position peaked at $64K in Q4 2022.
  • 86 funds tracked by Wall St. Rank held Adicet Bio as of Q2 2024.

Based on Zurich Cantonal Bank's 13F filing for Q2 2024, filed 29 Jul 2024.